# Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC)

Source: https://onco.cc/trials/nct05913674/  
OnCo record `nct05913674` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial in colorectal cancer, run by Ciusss de L'Est de l'Île de Montréal, now recruiting.

## Summary

Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC) is a phase 2, interventional study registered as NCT05913674 by Ciusss de L'Est de l'Île de Montréal, with a registry enrolment figure of 25 participants, started 2026-05-01 and due to reach its primary completion in 2028-05. Interventions recorded: Modified early post-operative intraperitoneal chemotherapy (mEPIC). Conditions listed: Peritoneal Carcinomatosis; Appendiceal Neoplasms; Colorectal Cancer Metastatic. Primary outcome: Feasibility of mEPIC. Colorectal eligibility wording from the registry: "* Histological diagnosis of appendicular or colorectal tumors with peritoneal carcinomatosis, either synchronous (\< 12 months after primary diagnosis) or metachronous (\>12 months after the primary diagnosis)". Sites: Canada. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Tags: ctgov-ingest; colorectal-deep-dive
- Registry id: NCT05913674
- Phase: 2
- Setting: Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC)
- Sponsor: Ciusss de L'Est de l'Île de Montréal
- Enrolled: 25

## Sources

- ClinicalTrials.gov NCT05913674: https://clinicaltrials.gov/study/NCT05913674

## Connected records

- cancers: [Colon cancer (adenocarcinoma of the colon)](https://onco.cc/cancers/colon-cancer/), [Rectal cancer](https://onco.cc/cancers/rectal-cancer/)
- terms: [Colorectal cancer trials open today (registry snapshot)](https://onco.cc/terms/colorectal-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct05913674.json